Status:
UNKNOWN
Mindfulness Intervention and Relapse in Psychosis
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
University Grants Committee, Hong Kong
Conditions:
Psychosis
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Practicing mindfulness is popular and well-accepted for its benefits in improving mental and physical health. In particular, its benefits in promoting resilience to stress and well-being have been sho...
Detailed Description
Objectives and hypotheses 1. Primary objective: • To examine if mindfulness-based intervention can reduce rates of relapse at 1 year in remitted patients with psychosis. 2. Secondary objectives: ...
Eligibility Criteria
Inclusion
- aged 18 to 55 years
- in full symptomatic remission for at least 6 months
- have been ill for no more than 3 years following first episode psychosis
- have sufficient proficiency in Chinese to understand verbal instructions and to give informed consent.
Exclusion
- known diagnosis of intellectual disability
- organic brain disorder
- current or previous use of illicit drugs
- substance-induced psychosis or alcohol intake in excess of 5 standard units per day
- people who practice mindfulness and meditation exercise for more than twice a week over the past 1 month.
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2023
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT04060498
Start Date
October 1 2019
End Date
October 1 2023
Last Update
September 20 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.